Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Blaise, D; Maraninchi, D; Michallet, M; Reiffers, J; Jouet, JP; Milpied, N; Devergie, A; Attal, M; Sotto, JJ; Kuentz, M; Ifrah, N; Duriac, C; Bordigoni, P; Gratecos, N; Guilhot, F; Guyotat, D; Gluckman, E; Vernant, JP
   Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission
   BLOOD
   
   D. Blaise et al., "Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission", BLOOD, 97(11), 2001, pp. 3669-3671
2. Boudard, D; Sordet, O; Vasselon, C; Revol, V; Bertheas, MF; Freyssenet, D; Viallet, A; Piselli, S; Guyotat, D; Campos, L
   Expression and activity of caspases 1 and 3 in myelodysplastic syndromes
   LEUKEMIA
   
   D. Boudard et al., "Expression and activity of caspases 1 and 3 in myelodysplastic syndromes", LEUKEMIA, 14(12), 2000, pp. 2045-2051
3. Michallet, M; Thiebaut, A; Philip, I; Charrin, C; Vigouroux, C; Thomas, X; Bilger, K; Belhabri, A; Guyotat, D; Corront, B; Salles, B; Dumontet, C; Peaud, PY; Vilque, JP; Devidas, A; Fiere, D
   Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha
   LEUKEMIA
   
   M. Michallet et al., "Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha", LEUKEMIA, 14(12), 2000, pp. 2064-2069
4. Prudhomme-Lacroix, F; Jaubert, J; Mosnier, JF; Guyotat, D
   Hodgkin's disease of the tonsil: clinical, histological, immunophenotypical features and association with Epstein-Barr virus
   PRESSE MEDICALE
   
   F. Prudhomme-Lacroix et al., "Hodgkin's disease of the tonsil: clinical, histological, immunophenotypical features and association with Epstein-Barr virus", PRESSE MED, 29(17), 2000, pp. 935-938
5. Harousseau, JL; Witz, B; Lioure, B; Hunault-Berger, M; Desablens, B; Delain, M; Guilhot, F; Le Prise, PY; Abgrall, JF; Deconinck, E; Guyotat, D; Vilque, JP; Casassus, P; Tournilhac, O; Audhuy, B; Solary, E
   Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques
   JOURNAL OF CLINICAL ONCOLOGY
   
   J.L. Harousseau et al., "Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques", J CL ONCOL, 18(4), 2000, pp. 780-787
6. Moukahal, MA; Jaubert, J; Guyotat, D
   Infectious complications in patients with common variable immunoglobulin deficiency. A retrospective case study.
   MEDECINE ET MALADIES INFECTIEUSES
   
   M.A. Moukahal et al., "Infectious complications in patients with common variable immunoglobulin deficiency. A retrospective case study.", MED MAL INF, 30(2), 2000, pp. 81-86
7. Michallet, M; Thomas, X; Vernant, JP; Kuentz, M; Socie, G; Esperou-Bourdeau, H; Milpied, N; Blaise, D; Rio, B; Reiffers, J; Jouet, JP; Cahn, JY; Bourhis, JH; Lioure, B; Leporrier, M; Sotto, JJ; Souillet, G; Sutton, L; Bordigoni, P; Dreyfus, F; Tilly, H; Gratecos, N; Attal, M; Leprise, PY; Demeocq, F; Michel, G; Buzyn, A; Delmas-Marsalet, B; Bernaudin, F; Ifrah, N; Sadoun, A; Guyotat, D; Cavazzana-Cavo, M; Caillot, D; De Revel, T; Vannier, JP; Baruchel, A; Fegueux, N; Tanguy, ML; Thiebaut, A; Belhabri, A; Archimbaud, E
   Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)
   BONE MARROW TRANSPLANTATION
   
   M. Michallet et al., "Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)", BONE MAR TR, 26(11), 2000, pp. 1157-1163
8. Michallet, M; Tanguy, ML; Socie, G; Thiebaut, A; Belhabri, A; Milpied, N; Reiffers, J; Kuentz, M; Cahn, JY; Blaise, D; Demeocq, F; Jouet, JP; Michallet, AS; Ifrah, N; Vilmer, E; Molina, L; Michel, G; Lioure, B; Cavazzana-Calvo, M; Pico, JL; Sadoun, A; Guyotat, D; Attal, M; Cure, H; Bordigoni, P; Sutton, L; Buzyn-Veil, A; Tilly, M; Leporrier, M; Fegueux, N; Dreyfus, F; Rio, B; Lutz, P; Vernant, JP
   Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)
   BRITISH JOURNAL OF HAEMATOLOGY
   
   M. Michallet et al., "Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)", BR J HAEM, 108(2), 2000, pp. 400-407
9. Campos, L; Sabido, O; Viallet, A; Vasselon, C; Guyotat, D
   Expression of apoptosis-controlling proteins in acute leukemia cells
   LEUKEMIA & LYMPHOMA
   
   L. Campos et al., "Expression of apoptosis-controlling proteins in acute leukemia cells", LEUK LYMPH, 33(5-6), 1999, pp. 499-509
10. Guyotat, D; Wahbi, K; Viallet, A; Piselli, S; Campos, L
    Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia
    LEUKEMIA
    
    D. Guyotat et al., "Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia", LEUKEMIA, 13(7), 1999, pp. 991-998
11. Michallet, M; Perrin, MC; Belhabri, A; Molina, L; Nicolini, F; Tigaud, JD; Sotto, JJ; Guyotat, D; Fiere, D; Archimbaud, E
    Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    M. Michallet et al., "Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation", BONE MAR TR, 23(2), 1999, pp. 145-150
12. Tardy-Poncet, B; Tardy, B; Reynaud, J; Mahul, P; Mismetti, P; Mazet, E; Guyotat, D
    Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia
    CHEST
    
    B. Tardy-Poncet et al., "Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia", CHEST, 115(6), 1999, pp. 1616-1620
13. Ifrah, N; Witz, F; Jouet, JP; Francois, S; Lamy, T; Linassier, C; Pignon, B; Berthou, C; Guyotat, D; Cahn, JY; Harousseau, JL
    Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia
    CANCER
    
    N. Ifrah et al., "Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia", CANCER, 86(8), 1999, pp. 1496-1505
14. Misery, L; Cambazard, F; Rimokh, R; Ghohestani, R; Magaud, JP; Gaudillere, A; Perrot, JL; Berard, F; Claudy, A; Guyotat, D; Schmitt, D; Vincent, C
    Bullous pemphigoid associated with chronic B-cell lymphatic leukaemia: theanti-230-kDa autoantibody is not synthesized by leukaemic cells
    BRITISH JOURNAL OF DERMATOLOGY
    
    L. Misery et al., "Bullous pemphigoid associated with chronic B-cell lymphatic leukaemia: theanti-230-kDa autoantibody is not synthesized by leukaemic cells", BR J DERM, 141(1), 1999, pp. 155-157
15. DACOSTA A; TARDYPONCET B; ISAAZ K; CERISIER A; MISMETTI P; SIMITSIDIS S; REYNAUD J; TARDY B; PIOT M; DECOUSUS H; GUYOTAT D
    PREVALENCE OF FACTOR-V-LEIDEN (APCR) AND OTHER INHERITED THROMBOPHILIAS IN YOUNG-PATIENTS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES
    HEART
    
    A. Dacosta et al., "PREVALENCE OF FACTOR-V-LEIDEN (APCR) AND OTHER INHERITED THROMBOPHILIAS IN YOUNG-PATIENTS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES", HEART, 80(4), 1998, pp. 338-340
16. BRUNET I; PARET D; ORIOL P; GUYOTAT D
    THE COLLABORATION BOOKLET - A VEHICLE OF INFORMATION SERVING THE PATIENT
    Bone marrow transplantation
    
    I. Brunet et al., "THE COLLABORATION BOOKLET - A VEHICLE OF INFORMATION SERVING THE PATIENT", Bone marrow transplantation, 21, 1998, pp. 907-907
17. MISERY L; GUYOTAT D; CAMBAZARD F
    LANGERHANS CELL HISTIOCYTOSIS AND ACUTE MONOCYTIC LEUKEMIA
    Annales de dermatologie et de venereologie
    
    L. Misery et al., "LANGERHANS CELL HISTIOCYTOSIS AND ACUTE MONOCYTIC LEUKEMIA", Annales de dermatologie et de venereologie, 125(10), 1998, pp. 732-733
18. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MAHE B; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; BUZYN A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; STAMATOULAS A; TILLY H; BRICE P; MALOISEL F; LIOURE B; DESABLENS B; PIGNON B; ABGRALL JP; LEPORRIER M; DUPRIEZ B; GUYOTAT D; LEPELLEY P; FENAUX P
    QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY
    British Journal of Haematology
    
    E. Wattel et al., "QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY", British Journal of Haematology, 102(4), 1998, pp. 1015-1024
19. GUYOTAT D; WAHBI K; VIALLET A; PISELLI S; PRALAS J; CAMPOS L
    SELECTION OF PH-1-NEGATIVE STEM-CELLS FROM BLOOD OR MARROW OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA
    British Journal of Haematology
    
    D. Guyotat et al., "SELECTION OF PH-1-NEGATIVE STEM-CELLS FROM BLOOD OR MARROW OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA", British Journal of Haematology, 102(1), 1998, pp. 181-181
20. CAMPOS L; BOUDARD D; SABIDO O; VIALLET A; PISELLI S; VASSELON C; GUYOTAT D
    IN-VITRO MODULATION OF CASPASE ACTIVITY IN MYELODYSPLASTIC SYNDROMES
    British Journal of Haematology
    
    L. Campos et al., "IN-VITRO MODULATION OF CASPASE ACTIVITY IN MYELODYSPLASTIC SYNDROMES", British Journal of Haematology, 102(1), 1998, pp. 281-281
21. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; VEIL A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; TILLY H; BRICE B; GUYOTAT D; LEPELLEY P; FENAUX P
    QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY
    British Journal of Haematology
    
    E. Wattel et al., "QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY", British Journal of Haematology, 102(1), 1998, pp. 282-282
22. GUILHOT F; MALOISEL F; GUERCI A; MICHALLET M; HAROUSSEAU JL; BRIERE J; ROCHANT H; CIURANA AJ; ABGRALL JF; GUYOTAT D; CHRISTIAN B; ORFEUVRE H
    UPDATE OF THE 810 CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH INTERFERON-ALPHA-2B OR IFN ALPHA-2B AND CYTARABINE
    British Journal of Haematology
    
    F. Guilhot et al., "UPDATE OF THE 810 CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH INTERFERON-ALPHA-2B OR IFN ALPHA-2B AND CYTARABINE", British Journal of Haematology, 102(1), 1998, pp. 282-283
23. WATTEL E; LELEU X; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET JP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGUEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
    AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
    British Journal of Haematology
    
    E. Wattel et al., "AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)", British Journal of Haematology, 102(1), 1998, pp. 320-321
24. PERRIN MC; JAUBERT J; REYNAUD J; MOUNIER C; ORIOL P; GUYOTAT D
    HIGH-INCIDENCE OF THROMBOTIC EVENTS IN MYELOMA PATIENTS
    British Journal of Haematology
    
    M.C. Perrin et al., "HIGH-INCIDENCE OF THROMBOTIC EVENTS IN MYELOMA PATIENTS", British Journal of Haematology, 102(1), 1998, pp. 355-355
25. CAMPOS L; ORIOL P; SABIDO O; GUYOTAT D
    SIMULTANEOUS EXPRESSION OF P-GLYCOPROTEIN AND BCL-2 IN ACUTE MYELOID-LEUKEMIA BLAST CELLS
    Leukemia & lymphoma
    
    L. Campos et al., "SIMULTANEOUS EXPRESSION OF P-GLYCOPROTEIN AND BCL-2 IN ACUTE MYELOID-LEUKEMIA BLAST CELLS", Leukemia & lymphoma, 27(1-2), 1997, pp. 119-125
26. MAYNADIE M; CAMPOS L; MOSKOVTCHENKO P; SABIDO O; AHO S; LENORMAND B; CARLI PM; GUYOTAT D; BENE MC; FAURE G; CAPIOD JC; GARDAIS J; FEUILLARD J; RAPHAEL M; LACOMBE R; LECALVEZ G; LEGLISE MC; DENEYS V; MASSON AM; BERNIER M; MALET AM; SALAUN C; BOURIN P; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; MOSKOVTCHENKO P; FAVRE M; BENSA JC; JACOB MC; WALLEF G; SARIAUX C; TRIMOREAU F; PRALORAN V; CAMPOS L; SABIDO O; VASSELON C; BRUNET C; PONCELET P; GUITARD AM; TAIB J; LAVABREBERTRAND T; JUNG G; KANDEL G; GARAND R; PHILIP P; SUDAKA I; MONPOUX F; VANHAEKE D; PERROT JY; MARIE JP; VALENSI F; VERGE V; HOMBERG JC; SCHAISON G; BOUMSELL L; DOUAY L; SAMSON T; BRIZARD A; DALIPHARD S; DRENOU B; LEES O; LENORMAND B; POILANE B; FALKENRODT A; ALBERT A; KUHLEIN E; ESTIENNE MH; BREMOND JL; DEGENNE M; LEBARON F; REUMAUX G; DUTHILLEUL P; BENE MC; FAURE G; BORDIGONI P; WITZ F; KOLLOPSARDA MN; BAYLE C; ANTONINI J; BOUCHEIX C; CHARPENTIER A
    HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS
    Leukemia & lymphoma
    
    M. Maynadie et al., "HETEROGENOUS EXPRESSION OF CD15 IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A STUDY OF 10 ANTI-CD15 MONOCLONAL-ANTIBODIES IN 158 PATIENTS", Leukemia & lymphoma, 25(1-2), 1997, pp. 135-143
27. DACOSTA A; TARDYPONCET B; ISAAZ K; CERISIER A; MISMETTI P; SIMITSIDIS S; RAYNAUD J; TARDY B; DECOUSUS H; GUYOTAT D
    PREVALENCE OF FACTOR-V-LEIDEN AND OF OTHER INHERITED THROMBOPHILIA INYOUNG-PATIENTS UNDER 45 YEARS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES - A PROSPECTIVE-STUDY
    Thrombosis and haemostasis
    
    A. Dacosta et al., "PREVALENCE OF FACTOR-V-LEIDEN AND OF OTHER INHERITED THROMBOPHILIA INYOUNG-PATIENTS UNDER 45 YEARS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES - A PROSPECTIVE-STUDY", Thrombosis and haemostasis, 1997, pp. 1280-1280
28. DACOSTA A; TARDYPONCET B; ISAAZ K; CERISIER A; MISMETTI P; SIMITSIDIS S; REYNAUD J; BACHONGY P; DECOUSUS H; GUYOTAT D
    FACTOR-V-LEIDEN AND ACUTE MYOCARDIAL-INFARCTION WITH NORMAL CORONARY-ARTERIES - A CASE-CONTROL STUDY
    Thrombosis and haemostasis
    
    A. Dacosta et al., "FACTOR-V-LEIDEN AND ACUTE MYOCARDIAL-INFARCTION WITH NORMAL CORONARY-ARTERIES - A CASE-CONTROL STUDY", Thrombosis and haemostasis, 1997, pp. 1284-1284
29. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; IFRAH N; ABGRALL JP; GUYOTAT D; DUPRIEZ B; PENY AM; BRICE P; PIGNON B; LEPORRIER M; LEPELLEY P; FENAUX P
    INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS)
    Experimental hematology
    
    E. Wattel et al., "INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS)", Experimental hematology, 25(8), 1997, pp. 34-34
30. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET JP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
    AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
    Experimental hematology
    
    E. Wattel et al., "AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)", Experimental hematology, 25(8), 1997, pp. 320-320
31. GUILHOT F; GUERCI A; MALOISEL F; MICHALLET M; HAROUSSEAU JL; BOUABDALLAH R; GUYOTAT D; ABGRALL JF; IFRAH N; BRIERE J; TERTIAN G; BAUTERS F; NAVARRO M; MORICE P; CHRISTINA B; VILQUE JM; BLANC M; CHASTANG C
    RELATIONSHIP BETWEEN CYTOGENETIC RESPONSE AND SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA - RESULTS OF 2 MULTICENTRIC TRIALS
    Experimental hematology
    
    F. Guilhot et al., "RELATIONSHIP BETWEEN CYTOGENETIC RESPONSE AND SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA - RESULTS OF 2 MULTICENTRIC TRIALS", Experimental hematology, 25(8), 1997, pp. 493-493
32. JOURDAN E; MARANINCHI D; REIFFERS J; GLUCKMAN E; RIO B; JOUET JP; MICHALLET M; MOLINA L; ARCHIMBAUD E; HAROUSSEAU JL; IFRAH N; ATTAL M; GUILHOT F; KUENTZ M; GUYOTAT D; PICO JL; DAURIAC C; LEGROS M; DREYFUS F; BORDIGONI P; LEBLOND V; GRATECOS N; VARET B; AUZANNEAU C; TILLY H; VILMER E; BARDOU VJ; BLAISE D
    EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA
    Bone marrow transplantation
    
    E. Jourdan et al., "EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA", Bone marrow transplantation, 19(9), 1997, pp. 875-881
33. GUILHOT F; CHASTANG C; MICHALLET M; GUERCI A; HAROUSSEAU JL; MALOISEL F; BOUABDALLAH R; GUYOTAT D; CHERON N; NICOLINI F; ABGRALL JF; TANZER J
    INTERFERON ALFA-2B COMBINED WITH CYTARABINE VERSUS INTERFERON ALONE IN CHRONIC MYELOGENOUS LEUKEMIA
    The New England journal of medicine
    
    F. Guilhot et al., "INTERFERON ALFA-2B COMBINED WITH CYTARABINE VERSUS INTERFERON ALONE IN CHRONIC MYELOGENOUS LEUKEMIA", The New England journal of medicine, 337(4), 1997, pp. 223-229
34. TARDY B; TARDYPONCET B; LAPORTESIMITSIDIS S; MISMETTI P; DECOUSUS H; GUYOTAT D; BERTRAND JC
    EVOLUTION OF BLOOD-COAGULATION AND FIBRINOLYSIS PARAMETERS AFTER ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN PATIENTS WITH VENOUS THROMBOEMBOLISM - A DOUBLE-BLIND RANDOMIZED STUDY
    British Journal of Haematology
    
    B. Tardy et al., "EVOLUTION OF BLOOD-COAGULATION AND FIBRINOLYSIS PARAMETERS AFTER ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN PATIENTS WITH VENOUS THROMBOEMBOLISM - A DOUBLE-BLIND RANDOMIZED STUDY", British Journal of Haematology, 96(1), 1997, pp. 174-178
35. HAROUSSEAU JL; CAHN JY; PIGNON B; WITZ F; MILPIED N; DELAIN M; LIOURE B; LAMY T; DESABLENS B; GUILHOT F; CAILLOT D; ABGRALL JF; FRANCOIS S; BRIERE J; GUYOTAT D; CASASSUS P; AUDHUY B; TELLIER Z; HURTELOUP P; HERVE P
    COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA
    Blood
    
    J.L. Harousseau et al., "COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA", Blood, 90(8), 1997, pp. 2978-2986
36. LIOURE B; WITZ F; DECONNINCK E; DELAIN M; SOLARY E; BERTHOU C; AUDHUY B; FRANCOIS S; GUYOTAT D; SADDOUN A; PIGNON B; HAROUSSEAU JL; OBERLING F
    AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP
    Blood
    
    B. Lioure et al., "AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP", Blood, 90(10), 1997, pp. 1710-1710
37. GUILHOT F; GUERCI A; MALOISEL F; HAROUSSEAU JL; BRIERE J; IFRAH N; ABGRALL JF; GUYOTAT D; CHRISTIAN B; BAUDUER F; JAUBERT D; MARTIN C; GUILHOT J; CHASTANG C
    FOLLOW-UP OF 1047 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA, TREATEDWITH INTERFERON OR INTERFERON AND CYTARABINE
    Blood
    
    F. Guilhot et al., "FOLLOW-UP OF 1047 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA, TREATEDWITH INTERFERON OR INTERFERON AND CYTARABINE", Blood, 90(10), 1997, pp. 2299-2299
38. CAMPOS L; SABIDO O; VIALLET A; PISELLI S; GUYOTAT D
    IMPLICATION OF ICE AND CPP32 IN THE IN-VITRO GROWTH DEFECTS OF COMMITTED PROGENITORS FROM MYELODYSPLASTIC SYNDROMES
    Blood
    
    L. Campos et al., "IMPLICATION OF ICE AND CPP32 IN THE IN-VITRO GROWTH DEFECTS OF COMMITTED PROGENITORS FROM MYELODYSPLASTIC SYNDROMES", Blood, 90(10), 1997, pp. 2323-2323
39. CAMPOS L; SABIDO O; SEBBAN C; CHARRIN C; BERTHEAS MF; FIERE D; GUYOTAT D
    EXPRESSION OF BCL-2 PROTOONCOGENE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
    Leukemia
    
    L. Campos et al., "EXPRESSION OF BCL-2 PROTOONCOGENE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA", Leukemia, 10(3), 1996, pp. 434-438
40. TARDYPONCET B; REYNAUD J; TARDY B; MAHUL P; MISMETTI P; BERAUD AM; REBAUD MA; BAYON M; GUYOTAT D
    ORG-10172 FOR HEPARIN-INDUCED THROMBOCYTO PENIA - TOLERANCE AND EFFICACY
    La Presse medicale
    
    B. Tardyponcet et al., "ORG-10172 FOR HEPARIN-INDUCED THROMBOCYTO PENIA - TOLERANCE AND EFFICACY", La Presse medicale, 25(16), 1996, pp. 751-755
41. GUILHOT F; GUERCI A; FIERE D; HAROUSSEAU JL; MALOISEL F; BOUABDALLAH R; GUYOTAT D; ROCHANT H; NAJMAN A; NICOLINI F; COLOMBAT P; ABGRALL JF; IFRAH N; BRIERE J; BAUTERS F; NAVARRO M; MORICE P; BORDESSOULE D; VILQUE JP; DESABLENS B; TERTIAN G; BLANC M; CHASTANG C; TANZER J
    THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA BY INTERFERON AND CYTOSINE-ARABINOSIDE - RATIONAL AND DESIGN OF THE FRENCH TRIALS
    Bone marrow transplantation
    
    F. Guilhot et al., "THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA BY INTERFERON AND CYTOSINE-ARABINOSIDE - RATIONAL AND DESIGN OF THE FRENCH TRIALS", Bone marrow transplantation, 17, 1996, pp. 29-31
42. TARDY B; TARDYPONCET B; BARA L; LAPORTESIMITSIDIS S; RASCLE F; SAMAMA MM; GUYOTAT D; BERTRAND JC
    EFFECTS OF LONG TRAVELS IN SITTING POSITION IN ELDERLY VOLUNTEERS ON BIOLOGICAL - MARKERS OF COAGULATION ACTIVATION AND FIBRINOLYSIS
    Thrombosis research
    
    B. Tardy et al., "EFFECTS OF LONG TRAVELS IN SITTING POSITION IN ELDERLY VOLUNTEERS ON BIOLOGICAL - MARKERS OF COAGULATION ACTIVATION AND FIBRINOLYSIS", Thrombosis research, 83(2), 1996, pp. 153-160
43. PIGNON B; WITZ F; DESABLENS B; LEPRISE PY; FRANCOIS S; LINASSIER C; BERTHOU C; CAILLOT D; LIOURE B; CAHN JY; CASASSUS P; SADOUN A; AUDHUY B; GUYOTAT D; BRIERE J; VILQUE JP; BARANGER L; POLIN V; BERTHAUD P; HURTELOUP P; HERVE P; HAROUSSEAU JL
    TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE
    British Journal of Haematology
    
    B. Pignon et al., "TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE", British Journal of Haematology, 94(2), 1996, pp. 333-341
44. CHARRIN C; MAGAUD JP; SEBBAN C; FIERE D; DASTUGUE N; HUGUETRIGAL F; ATTAL M; SIE P; LAI JL; JOUET JP; SIMON M; ZANDECKI M; GREGOIRE MJ; WITZ F; WITZ B; BARIN C; MORAINE C; MUGNERET F; FAVRE B; RAYNAUD S; GRATECOS N; THYSS A; AYRAUD N; LAFAGE M; AMOULET C; SAINTY D; MOZZICONACCI MJ; STOPPA AM; BERNARD P; REIFFERS J; BARANGER L; BOASSON M; IFRAH N; VANDENAKKER J; PERROT C; BERTHEAS MF; VASSELON C; CALMARD P; GUYOTAT D; TALMANT P; UETTWILLER F; MALOLSEL F; RUCH JV; OBERLING F; WEH HJ; VERELLENDUMOULIN C; LIBOUTON JM; DELANNOY A; FERRANT A; MICHAUX JL; DESANGLES F; RIVIERE D; PLUCHONRIVIERE E; BERTHOU C; PEDRON MF; NOEL B; LESPINASSE J; MECUCCI C; VANDENBERGHE H; BERGER R; POLSSONNIER M; NOEL L; GARDIN C; TURELURE P; VERHEST A; GIOLLANT M; DOSSANTOS E; TOUMILHAC O; RAMOND S; DREYFUS F; ZITTOUN R; SMADJA N; KRULIK M; SCHOENWALD M; VAUGLER GL; LEBLOND V; HURET JL; GIRAUD C; TANZER J; ECLACHE V; CAPODANO AM; ZATTARACANNONI H; LEONARD C; TCHERNIA G
    CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE (VOL 87, PG 3135, 1996)
    Blood
    
    C. Charrin et al., "CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE (VOL 87, PG 3135, 1996)", Blood, 88(7), 1996, pp. 2818-2818
45. SOLARY E; WITZ B; CAILLOT D; MOREAU P; DESABLENS B; CAHN JY; SADOUN A; PIGNON B; BERTHOU C; MALOISEL F; GUYOTAT D; CASASSUS P; IFRAH N; LAMY Y; AUDHUY B; COLOMBAT P; HAROUSSEAU JL
    COMBINATION OF QUININE AS A POTENTIAL REVERSING AGENT WITH MITOXANTRONE AND CYTARABINE FOR THE TREATMENT OF ACUTE LEUKEMIAS - A RANDOMIZED MULTICENTER STUDY
    Blood
    
    E. Solary et al., "COMBINATION OF QUININE AS A POTENTIAL REVERSING AGENT WITH MITOXANTRONE AND CYTARABINE FOR THE TREATMENT OF ACUTE LEUKEMIAS - A RANDOMIZED MULTICENTER STUDY", Blood, 88(4), 1996, pp. 1198-1205
46. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; JOUET IP; HOANGNGOC L; MALOISEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; GUYOTAT D; BRICE P; LEPELLEY P; FENAUX P
    PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
    Blood
    
    E. Wattel et al., "PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)", Blood, 88(10), 1996, pp. 507-507
47. GUILHOT F; CHASTANG C; GUERCI A; MICHALLET M; HAROUSSEAU JL; MALOISEL F; BRIERE J; BOUABDALLAH R; GUYOTAT D; TERTIAN G; NICOLINI F; ABGRALL JF; NAVARRO M; BLANC M; BRICE P; SIMON M; IFRAH N; ROCHANT F; VILQUE JP; DELAIN M; GUILHOT J; TANZER J
    INTERFERON ALPHA2B (IFN) AND CYTARABINE (ARA-C) SURVIVAL AND CYTOGENETIC RESPONSE IN CHRONIC LEUKEMIA (CML) - RESULTS OF A RANDOMIZED TRIAL
    Blood
    
    F. Guilhot et al., "INTERFERON ALPHA2B (IFN) AND CYTARABINE (ARA-C) SURVIVAL AND CYTOGENETIC RESPONSE IN CHRONIC LEUKEMIA (CML) - RESULTS OF A RANDOMIZED TRIAL", Blood, 88(10), 1996, pp. 551-551
48. WATTEL E; SOLARY E; CAILLOT D; DREYFUS F; BRION A; MAHE B; HOANGNGOC L; MALOSIEL F; GUERCI A; ROCHANT H; GRATECOS N; SADOUN A; STAMATOULLAS A; CASASSUS P; JANVIER M; STOPPA AM; DESABLENS B; FEGEUX N; IFRAH N; ABGRALL IP; GUYOTAT D; DUPRIEZ B; PENY AM; BRICE P; PIGNON B; LEPORRIER M; LEPELLEY P; FENAUX P
    QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP)
    Blood
    
    E. Wattel et al., "QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP)", Blood, 88(10), 1996, pp. 1807-1807
49. GUYOTAT D; VIALLET A; SABIDO O; CAMPOS L
    EXPRESSION OF BCL-2-RELATED AND ICE-RELATED PROTEINS IN ACUTE MYELOIDLEUKEMIAS (AML) AND MYELODYSPLASTIC SYNDROMES (MDS)
    Blood
    
    D. Guyotat et al., "EXPRESSION OF BCL-2-RELATED AND ICE-RELATED PROTEINS IN ACUTE MYELOIDLEUKEMIAS (AML) AND MYELODYSPLASTIC SYNDROMES (MDS)", Blood, 88(10), 1996, pp. 2250-2250
50. CHARRIN C; MAGAUD JP; SEBBAN C; FIERE D; DASTUGUE N; HUGUETRIGAL F; ATTAL M; SIE P; LAI JL; JOUET JP; SIMON M; ZANDECKI M; GREGOIRE MJ; WITZ F; WITZ B; BARIN C; MORAINE C; MUGNERET F; FAVRE B; RAYNAUD S; BAUDOIN F; GRATECOS N; THYSS A; AYRAUD N; LAFAGE M; ARNOULET C; SAINTY D; MOZZICONACCI MJ; STOPPA AM; BERNARD P; REIFFERS J; VANDENAKKER J; PERROT C; BERTHEAS MF; VASSELON C; CALMARD P; GUYOTAT D; TALMANT P; UETTWILLER F; MALOISEL F; RUCH JV; OBERLING F; WEH HJ; VERELLENDUMOULIN C; LIBOUTON JM; DELANNOY A; FERRANT A; MICHAUX JL; DESANGLES F; RIVIERE D; PLUCHONRIVIERE E; BERTHOU C; PEDRON MF; NOEL B; LESPINASSE J; MECUCCI C; VANDENBERGHE H; BERGER R; POISSONNIER M; NOEL L; GARDIN C; TURELURE P; VERHEST A; GIOLLANT M; DOSSANTOS E; TOURNILHAC O; RAMOND S; DREYFUS F; ZITTOUN R; SMADJA N; KRULIK M; SCHOENWALD M; VAUGIER GL; LEBLOND V; HURET JL; GIRAUD C; TANZER J; ECLACHE V; CAPODANO AM; ZATTARACANNONI H; LEONARD C; TCHERNIA G
    CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE
    Blood
    
    C. Charrin et al., "CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATIONS WITH HEMATOLOGIC FINDINGS AND OUTCOME - A COLLABORATIVE STUDY OF THE GROUPE-FRANCAIS-DE-CYTOGENETIQUE-HEMATOLOGIQUE", Blood, 87(8), 1996, pp. 3135-3142
51. CAMPOS L; GUYOTAT D
    EXPRESSION OF THY-1 ANTIGEN (CDW90) ON ADULT ACUTE-LEUKEMIA BLAST CELLS
    Blood
    
    L. Campos e D. Guyotat, "EXPRESSION OF THY-1 ANTIGEN (CDW90) ON ADULT ACUTE-LEUKEMIA BLAST CELLS", Blood, 87(1), 1996, pp. 413-414
52. MISERY L; GUYOTAT D; BOUCHERON S; CLAUDY A
    ARE NEUTROPHILIC DERMATOSES DURING GRANULOCYTOPENIA REALLY NEUTROPHILIC
    Archives of dermatology
    
    L. Misery et al., "ARE NEUTROPHILIC DERMATOSES DURING GRANULOCYTOPENIA REALLY NEUTROPHILIC", Archives of dermatology, 132(7), 1996, pp. 832-832
53. CAMPOS L; SABIDO O; VIALLET A; GUYOTAT D
    REACTIVITY OF CD34 MONOCLONAL-ANTIBODIES WITH HEMATOPOIETIC PROGENITORS AND ACUTE LEUKEMIAS
    Tissue antigens
    
    L. Campos et al., "REACTIVITY OF CD34 MONOCLONAL-ANTIBODIES WITH HEMATOPOIETIC PROGENITORS AND ACUTE LEUKEMIAS", Tissue antigens, 48(4-II), 1996, pp. 609-609
54. VANHAEKE DR; BENE MC; GARAND R; FAURE GC; GARDAIS J; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; CHRETIEN P; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND T; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; VANHAEKE D; BERNARD A; VALENSI F; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; BRIZARD A; DALIPHARD S; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
    EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
    Leukemia & lymphoma
    
    D.R. Vanhaeke et al., "EXPRESSION AND LONG-TERM PROGNOSTIC VALUE OF CD34 IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA", Leukemia & lymphoma, 20(1-2), 1995, pp. 137-142
55. FARREL V; SCHMITT T; STEPHAN JL; GUYOTAT D; PUEL G; CALMARDORIOL P; JAUBERT J; TALABARD JN; FREYCON F
    TOTAL-BODY IRRADIATION (TBI) BEFORE BONE-MARROW GRAFTING (BMG) - ANALYSIS OF LATE SIDE-EFFECTS
    European journal of cancer
    
    V. Farrel et al., "TOTAL-BODY IRRADIATION (TBI) BEFORE BONE-MARROW GRAFTING (BMG) - ANALYSIS OF LATE SIDE-EFFECTS", European journal of cancer, 31A, 1995, pp. 1128-1128
56. JOURDAN E; MARANINCHI D; REIFFERS J; ARCHIMBAUD E; MICHALLET M; HAROUSSEAU JL; IFRAH N; RIO B; GUYOTAT D; GUILHOT F; ATTAL M; LEBLOND V; DAURIAC C; LEGROS M; PICO JL; MARIT G; BLAISE D
    ALLOGENEIC BONE-MARROW TRANSPLANTATION REMAINS AN EFFICIENT CONSOLIDATION FOR ADULTS WITH ACUTE MYELOID-LEUKEMIA EVEN WHEN PERFORMED VERY SOON AFTER DIAGNOSIS (LESS-THAN-100 DAYS)
    Leukemia
    
    E. Jourdan et al., "ALLOGENEIC BONE-MARROW TRANSPLANTATION REMAINS AN EFFICIENT CONSOLIDATION FOR ADULTS WITH ACUTE MYELOID-LEUKEMIA EVEN WHEN PERFORMED VERY SOON AFTER DIAGNOSIS (LESS-THAN-100 DAYS)", Leukemia, 9(6), 1995, pp. 1068-1071
57. COIGNET L; BERTHEAS MF; FRAPPAZ D; CALMARDORIOL P; JAUBERT J; VINDIMIAN M; BRIZARD CP; FREYCON F; GUYOTAT D
    FOLLOW-UP OF BONE-MARROW TRANSPLANTATION USING MINISATELLITE MS-31 AND MS-43 PROBES - COMPARISON WITH CHROMOSOMAL-POLYMORPHISM DATA
    La Presse medicale
    
    L. Coignet et al., "FOLLOW-UP OF BONE-MARROW TRANSPLANTATION USING MINISATELLITE MS-31 AND MS-43 PROBES - COMPARISON WITH CHROMOSOMAL-POLYMORPHISM DATA", La Presse medicale, 24(11), 1995, pp. 523-526
58. TARDY B; TARDYPONCET B; SIMITSIDIS S; DECOUSUS H; MISMETTI P; LEIZOROVICZ A; BERTRAND JC; GUYOTAT D
    ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN VENOUS THROMBOEMBOLIC DISEASE - A DOUBLE-BLIND RANDOMIZED STUDY
    Thrombosis and haemostasis
    
    B. Tardy et al., "ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN VENOUS THROMBOEMBOLIC DISEASE - A DOUBLE-BLIND RANDOMIZED STUDY", Thrombosis and haemostasis, 73(6), 1995, pp. 1119-1119
59. TARDYPONCET B; REYNAUD J; TARDY B; MAHUL P; MISMETTI P; DECOUSUS H; GUYOTAT D
    EFFICACY AND SAFETY OF ORGARAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
    Thrombosis and haemostasis
    
    B. Tardyponcet et al., "EFFICACY AND SAFETY OF ORGARAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA", Thrombosis and haemostasis, 73(6), 1995, pp. 1323-1323
60. CAMPOS L; ROUBI N; GUYOTAT D
    DEFINITION OF OPTIMAL CONDITIONS FOR COLLECTION AND CRYOPRESERVATION OF UMBILICAL-CORD HEMATOPOIETIC-CELLS
    Cryobiology
    
    L. Campos et al., "DEFINITION OF OPTIMAL CONDITIONS FOR COLLECTION AND CRYOPRESERVATION OF UMBILICAL-CORD HEMATOPOIETIC-CELLS", Cryobiology, 32(6), 1995, pp. 511-515
61. TARDYPONCET B; MAHUL P; BERAUD AM; FAVRE JP; TARDY B; GUYOTAT D
    FAILURE OF ORGARAN THERAPY IN A PATIENT WITH A PREVIOUS HEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME
    British Journal of Haematology
    
    B. Tardyponcet et al., "FAILURE OF ORGARAN THERAPY IN A PATIENT WITH A PREVIOUS HEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME", British Journal of Haematology, 90(4), 1995, pp. 969-970
62. MICHALLET M; MOULLET I; ARCHIMBAUD E; TARDY JC; DHEDIN N; BELHABRI A; GUYOTAT D; TIGAUD JD; AYMARD M; FIERE D
    RETROSPECTIVE STUDY OF HEPATITIS-C VIRUS-INFECTION IN 244 PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANT (1980 TO 1993)
    Blood
    
    M. Michallet et al., "RETROSPECTIVE STUDY OF HEPATITIS-C VIRUS-INFECTION IN 244 PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANT (1980 TO 1993)", Blood, 86(10), 1995, pp. 855-855
63. WITZ F; HAROUSSEAU JL; SADOUN A; GUYOTAT D; BERTHOU C; CAHN JY; GARDIN C; LIOURE B; WITZ B; DESABLENS B; IFRAH N; PIGNON B; LEPRISE PY; AUDHUY B; CAILLOT D; CASASSUS P; LINASSIER P; CHRISTIAN B; HURTELOUP P; POLIN V; TELLIER Z
    GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
    Blood
    
    F. Witz et al., "GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)", Blood, 86(10), 1995, pp. 2036-2036
64. CAMPOS L; GUYOTAT D
    EXPRESSION OF THY-1 (CDW90) ON ADULT ACUTE-LEUKEMIA BLAST CELLS
    Blood
    
    L. Campos e D. Guyotat, "EXPRESSION OF THY-1 (CDW90) ON ADULT ACUTE-LEUKEMIA BLAST CELLS", Blood, 86(10), 1995, pp. 2997-2997
65. GUYOTAT D; SEBBAN C; BERTHEAS MF; CHARRIN C; FIERE D; CAMPOS L
    SIGNIFICANCE OF BCL-2 PROTOONCOGENE EXPRESSION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS
    Blood
    
    D. Guyotat et al., "SIGNIFICANCE OF BCL-2 PROTOONCOGENE EXPRESSION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS", Blood, 86(10), 1995, pp. 3033-3033
66. SOLARY E; WITZ B; CAILLOT D; MOREAU P; DESABLENS B; CAHN JY; MALOISEL F; SADOUN A; PIGNON B; GUYOTAT D; CASASSUS P; IFRAH N; AUDHUY B; BERTHOU C; DELAIN M; LAMY T; HAROUSSEAU JL
    PROSPECTIVE MULTICENTRIC RANDOMIZED STUDY OF QUININE AS A POTENTIAL MDR-REVERSING AGENT FOR THE TREATMENT OF ACUTE LEUKEMIAS
    Blood
    
    E. Solary et al., "PROSPECTIVE MULTICENTRIC RANDOMIZED STUDY OF QUININE AS A POTENTIAL MDR-REVERSING AGENT FOR THE TREATMENT OF ACUTE LEUKEMIAS", Blood, 86(10), 1995, pp. 3109-3109
67. WATTEL P; SOLARY E; CAILLOT D; IFRAH N; BRIAN A; MAHE B; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; VEIL A; STOPPA AM; GRATECOS N; SADOUN A; TILLY H; BRICE P; LIOURE B; DESABLENS E; PIGNON B; ABGRALL IP; LEPORRIER M; DUPRIEZ B; GUYOTAT D; MERLAT A; FENAUX P
    INTENSIVE CHEMOTHERAPY (CT) WITH OR WITHOUT QUININE FOLLOWED BY AUTOLOGOUS BMT IN MYELODYSPLASTIC SYNDROMES (MDS) AND SECONDARY LEUKEMIAS (SL) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL
    Blood
    
    P. Wattel et al., "INTENSIVE CHEMOTHERAPY (CT) WITH OR WITHOUT QUININE FOLLOWED BY AUTOLOGOUS BMT IN MYELODYSPLASTIC SYNDROMES (MDS) AND SECONDARY LEUKEMIAS (SL) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL", Blood, 86(10), 1995, pp. 3204-3204
68. DEVERGIE A; BLAISE D; ATTAL M; TIGAUD JD; JOUET JP; VERNANT JP; BORDIGONI P; IFRAH N; DAURIAC C; CAHN JY; LIOURE B; TROUSSARD X; REIFFERS J; GRATECOS N; MILPIED N; BELANGER C; GUYOTAT D; TILLY H; MICHALLET M; GLUCKMAN E
    ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN FIRST CHRONIC PHASE - A RANDOMIZED TRIAL OF BUSULFAN-CYTOXAN VERSUS CYTOXAN-TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN - A REPORT FROM THE FRENCH-SOCIETY-OF-BONE-MARROW-GRAFT (SFGM)
    Blood
    
    A. Devergie et al., "ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN FIRST CHRONIC PHASE - A RANDOMIZED TRIAL OF BUSULFAN-CYTOXAN VERSUS CYTOXAN-TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN - A REPORT FROM THE FRENCH-SOCIETY-OF-BONE-MARROW-GRAFT (SFGM)", Blood, 85(8), 1995, pp. 2263-2268
69. GARAND R; BENE MC; GARDAIS J; DUBOSCMARCHENAY N; LACOMBE F; LEGLISE MC; LECALVEZ G; BERNIER M; MASSY M; GRIVEAU AM; BROUTARD P; LEBRUN C; BONHOMME J; CHASSAGNE B; DEMEOCQ F; RAPATEL C; TAVERNIER F; JOUAULT H; LELONG F; SOLARY E; CASASNOVAS RO; MAYNADIE M; BENSA JC; FAVRE M; JACOB MC; SARTIAUX C; HUART JL; DROUET M; PRALORAN V; TRIMOREAU F; CAMPOS L; LARESE A; PONCELET P; BESSONFAURE I; BRUNET C; LAVABREBERTRAND TL; TAIB J; KANDEL G; JUNG G; HARROUSSEAU JL; PHILIP P; MONPOUX F; BAUDOUIN F; SUDAKA I; CALDANI C; POMIER G; BERNARD A; REGUER M; SCHILL H; BOURIN P; ARBORIO M; SCHAISON G; BOUMSELL L; ADAM M; DOUAI L; VANHAECKE D; BRIZARD A; ROUALET JP; TABARY T; CHAUMAREL I; GENETET N; FAUCHET R; DRENOU B; LEES O; LENORMAND B; VANNIER JP; LEPETIT JC; ACQUART S; SABIDO O; GUYOTAT D; VASSELON C; FALKENRODT A; ALBERT A; BREMOND JL; GEORGET MT; ROUBINET F; KUHLEIN E; LEBARON F; DUTHILLEUL P; REUMAUX F; FAURE G; KOLOPPSARDA MN; BORDIGONI P; WITZ F; BAYLE C; ANTONINI J; CHARPENTIER A
    A NEW APPROACH OF ACUTE LYMPHOBLASTIC-LEUKEMIA IMMUNOPHENOTYPIC CLASSIFICATION - 1984-1994 THE GEIL EXPERIENCE
    Leukemia & lymphoma
    
    R. Garand et al., "A NEW APPROACH OF ACUTE LYMPHOBLASTIC-LEUKEMIA IMMUNOPHENOTYPIC CLASSIFICATION - 1984-1994 THE GEIL EXPERIENCE", Leukemia & lymphoma, 13, 1994, pp. 1-5
70. SHEN N; FFRENCH P; GUYOTAT D; FFRENCH M; FIERE D; BRYON PA; DECHAVANNE M
    EXPRESSION OF ADHESION MOLECULES IN ENDOTHELIAL-CELLS DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    European journal of haematology
    
    N. Shen et al., "EXPRESSION OF ADHESION MOLECULES IN ENDOTHELIAL-CELLS DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION", European journal of haematology, 52(5), 1994, pp. 296-301
71. ARCHIMBAUD E; THOMAS X; MICHALLET M; JAUBERT J; TRONCY J; GUYOTAT D; FIERE D
    PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA
    Journal of clinical oncology
    
    E. Archimbaud et al., "PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA", Journal of clinical oncology, 12(2), 1994, pp. 262-267
72. SOLARY E; GENNE P; WITZ B; MILPIED N; CAHN JY; MALOISEL F; QUIQUANDON I; SADOUN A; IFRAH N; CASASSUS P; BERTHOUX P; AUDHUY B; PIGNON B; LAMY T; GUYOTAT D; COLOMBAT P; STOPPA AM; KUENTZ M; GUY H; HAROUSSEAU JL
    CLINICAL-TRIALS OF THERAPEUTIC MDR REVERS ION IN ACUTE LEUKEMIAS
    Pathologie et biologie
    
    E. Solary et al., "CLINICAL-TRIALS OF THERAPEUTIC MDR REVERS ION IN ACUTE LEUKEMIAS", Pathologie et biologie, 42(10), 1994, pp. 924-925
73. TARDYPONCET B; TARDY B; GRELAC F; REYNAUD J; MISMETTI P; BERTRAND JC; GUYOTAT D
    PENTOSAN POLYSULFATE-INDUCED THROMBOCYTOPENIA AND THROMBOSIS
    American journal of hematology
    
    B. Tardyponcet et al., "PENTOSAN POLYSULFATE-INDUCED THROMBOCYTOPENIA AND THROMBOSIS", American journal of hematology, 45(3), 1994, pp. 252-257
74. MISERY L; BLANC L; PERROT JL; BOUCHERON S; VASSELON C; GUYOTAT D; CLAUDY A
    SWEETS-SYNDROME OCCURRING DURING AGRANULO CYTOSIS - PHYSIOPATHOLOGICAL HYPOTHESIS
    Annales de dermatologie et de venereologie
    
    L. Misery et al., "SWEETS-SYNDROME OCCURRING DURING AGRANULO CYTOSIS - PHYSIOPATHOLOGICAL HYPOTHESIS", Annales de dermatologie et de venereologie, 121(5), 1994, pp. 414-415
75. SOLARY E; WITZ F; MOREAU P; QUIQUANDON I; GENNE P; FLESCH M; SADDOUN A; MALOISEL F; PIGNON B; ABGRALL JF; GUYOTAT D; CASASSUS P; GARDEMBAS M; LAMY Y; AUDHUY B; LINASSIER C; CAILLOT D; HAROUSSEAU JL
    MITOXANTRONE-ARACYTINE WITH OR WITHOUT QU ININE IN THE TREATMENT OF ACUTE-LEUKEMIA, RESISTANT OR IN REMISSION
    Nouvelle revue francaise d'hematologie
    
    E. Solary et al., "MITOXANTRONE-ARACYTINE WITH OR WITHOUT QU ININE IN THE TREATMENT OF ACUTE-LEUKEMIA, RESISTANT OR IN REMISSION", Nouvelle revue francaise d'hematologie, 36, 1994, pp. 190000141-190000143
76. CAMPOS L; SABIDO O; ROUAULT JP; GUYOTAT D
    EFFECTS OF BCL-2 ANTISENSE OLIGODEOXYNUCLEOTIDES ON IN-VITRO PROLIFERATION AND SURVIVAL OF NORMAL MARROW PROGENITORS AND LEUKEMIC-CELLS
    Blood
    
    L. Campos et al., "EFFECTS OF BCL-2 ANTISENSE OLIGODEOXYNUCLEOTIDES ON IN-VITRO PROLIFERATION AND SURVIVAL OF NORMAL MARROW PROGENITORS AND LEUKEMIC-CELLS", Blood, 84(2), 1994, pp. 595-600
77. WITZ F; HAROUSSEAU JL; CAHN JY; ABGRALL JF; BRIERE J; SADOUN A; GUYOTAT D; HURTELOUP P; MERCIER M; BERTHAUD P
    GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
    Blood
    
    F. Witz et al., "GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)", Blood, 84(10), 1994, pp. 10000231-10000231
78. HAROUSSEAU JL; PIGNON B; WITZ F; LINASSIER P; LIOURE B; LEPRISE PY; CAHN JY; DESABLENS B; CAILLOT D; IFRAH N; ABGRALL JF; SADOUN A; GUYOTAT D; MORS A; CASASSUS P; BRIERE J; POLIN V; BERTHAUD P; HURTELOUP P
    PROSPECTIVE COMPARISON OF ALLOGENIC BONE-MARROW TRANSPLANTATION (ALLO-BMT), INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) AND UNPURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AS POST REMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA (AML)
    Blood
    
    J.L. Harousseau et al., "PROSPECTIVE COMPARISON OF ALLOGENIC BONE-MARROW TRANSPLANTATION (ALLO-BMT), INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) AND UNPURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AS POST REMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA (AML)", Blood, 84(10), 1994, pp. 10000251-10000251
79. CAMPOS L; SABIDO O; GUYOTAT D
    IN-VITRO MODULATION OF BCL-2 AND P170 GLYCOPROTEIN EXPRESSION IN CD34-POSITIVE PROGENITOR CELLS BY HEMATOPOIETIC GROWTH-FACTORS
    Blood
    
    L. Campos et al., "IN-VITRO MODULATION OF BCL-2 AND P170 GLYCOPROTEIN EXPRESSION IN CD34-POSITIVE PROGENITOR CELLS BY HEMATOPOIETIC GROWTH-FACTORS", Blood, 84(10), 1994, pp. 10000267-10000267
80. MICHALLET M; ARCHIMBAUD E; MOLINA L; PERRIN MC; BELHABRI A; GUYOTAT D; NICOLINI F; TIGAUD JD; HOLLARD D; FIERE D
    IMPACT OF GRAFT-VERSUS-HOST DISEASE PROPHYLACTIC AND THERAPEUTIC MANAGEMENT ON SURVIVAL AND DURATION OF COMPLETE REMISSION
    Blood
    
    M. Michallet et al., "IMPACT OF GRAFT-VERSUS-HOST DISEASE PROPHYLACTIC AND THERAPEUTIC MANAGEMENT ON SURVIVAL AND DURATION OF COMPLETE REMISSION", Blood, 84(10), 1994, pp. 10000335-10000335
81. BLAISE D; OLIVE D; ARCHIMBAUD E; REIFFERS J; LEBLOND V; MICHALLET M; VERNANT JP; IFRAH N; BELLANGER C; ATTAL M; MILPIED N; MARIT G; GUYOTAT D; CAUDRELIER P; HIRN M; MARANINCHI D
    GVHD PROPHYLAXIS WITH AN ANTI-IL2 RECEPTOR MONOCLONAL-ANTIBODY - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL IN STANDARD RISK LEUKEMIA
    Blood
    
    D. Blaise et al., "GVHD PROPHYLAXIS WITH AN ANTI-IL2 RECEPTOR MONOCLONAL-ANTIBODY - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL IN STANDARD RISK LEUKEMIA", Blood, 84(10), 1994, pp. 10000539-10000539
82. JOURDAN E; BLAISC D; REIFFERS J; GLUCKMAN E; RIO B; JOUET JP; MICHALLET M; ARCHIMBAUD E; HAROUSSEAU JL; IFRAH N; ATTAL M; GUILHOT F; KUENTZ M; GUYOTAT D; PICO JL; DAURIAC C; LEGROS M; DREYFUS F; BORDIGONI P; LEBLOND V; GRATECOS N; VARET B; AUZANNCAU C; TILLY H; VILMER E; MARANINCHI D
    ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT WITH ACUTE MYELOID-LEUKEMIA IN 1ST COMPLETE REMISSION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE
    Blood
    
    E. Jourdan et al., "ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT WITH ACUTE MYELOID-LEUKEMIA IN 1ST COMPLETE REMISSION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE", Blood, 84(10), 1994, pp. 10000712-10000712
83. MISERY L; CAMPOS L; SABIDO O; KANITAKIS J; DEZUTTERDAMBUYANT C; GUYOTAT D; SCHMITT D
    S100 PROTEIN AND NEURON-SPECIFIC ENOLASE ON MONOCYTIC LEUKEMIC CD1+ CELLS, PROBABLE PRECURSORS OF LANGERHANS CELLS
    European journal of haematology
    
    L. Misery et al., "S100 PROTEIN AND NEURON-SPECIFIC ENOLASE ON MONOCYTIC LEUKEMIC CD1+ CELLS, PROBABLE PRECURSORS OF LANGERHANS CELLS", European journal of haematology, 51(3), 1993, pp. 132-135
84. TARDY B; TARDYPONCET B; REYNAUD J; LAPORTESIMITSIDIS S; BORDET JC; PAGE Y; DECOUSUS H; GUYOTAT D; BERTRAND JC
    EVOLUTION OF BIOLOGICAL MARKERS OF HEMOSTATIC ACTIVATION AFTER A LONGTRAVEL IN SITTING POSITION IN ELDER VOLUNTEERS
    Thrombosis and haemostasis
    
    B. Tardy et al., "EVOLUTION OF BIOLOGICAL MARKERS OF HEMOSTATIC ACTIVATION AFTER A LONGTRAVEL IN SITTING POSITION IN ELDER VOLUNTEERS", Thrombosis and haemostasis, 69(6), 1993, pp. 629-629
85. TARDYPONCET B; REYNAUD J; RICHARD O; LAPORTESIMITSIDIS S; GOUNOT R; GUYOTAT D
    WHAT ARE THE NORMAL VALUES OF THE COAGULATION INHIBITORS IN CHILDREN
    Thrombosis and haemostasis
    
    B. Tardyponcet et al., "WHAT ARE THE NORMAL VALUES OF THE COAGULATION INHIBITORS IN CHILDREN", Thrombosis and haemostasis, 69(6), 1993, pp. 901-901
86. SHEN N; FFRENCH P; VILLE D; GUYOTAT D; FFRENCH M; HANSS M; FIERE D; BRYON PA; DECHAVANNE M
    EXPRESSION OF ADHESION MOLECULES IN ENDOTHELIAL-CELLS DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    Thrombosis and haemostasis
    
    N. Shen et al., "EXPRESSION OF ADHESION MOLECULES IN ENDOTHELIAL-CELLS DURING ALLOGENEIC BONE-MARROW TRANSPLANTATION", Thrombosis and haemostasis, 69(6), 1993, pp. 1187-1187
87. CALLET E; BERTHEAS MF; CAMPOS L; COIGNET L; CALMARDORIOL P; ROUBI N; VASSELON C; GUYOTAT D
    IDENTIFICATION OF CLONAL ORIGIN OF LEUKEMIC BONE-MARROW COLONIES IN ACUTE MYELOID-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS) USING FLUORESCENCE IN-SITU HYBRIDIZATION WITH SPECIFIC CHROMOSOME PROBES
    Experimental hematology
    
    E. Callet et al., "IDENTIFICATION OF CLONAL ORIGIN OF LEUKEMIC BONE-MARROW COLONIES IN ACUTE MYELOID-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS) USING FLUORESCENCE IN-SITU HYBRIDIZATION WITH SPECIFIC CHROMOSOME PROBES", Experimental hematology, 21(8), 1993, pp. 1154-1154
88. SUTTON L; KUENTZ M; CORDONNIER C; BLAISE D; DEVERGIE A; GUYOTAT D; LEBLOND V; FLESCH M; BORDIGONI P; ATTAL M; REIFFERS J; IFRAH N; MILPIED N; GRATECOS N; CAILLOT D; TROUSSARD X; BELANGER C; FACON T; PICO JL; MICHALLET M; RIO B; LIOURE B; VERNANT JP
    ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - FACTORS PREDICTIVE OF TRANSPLANT-RELATED MORTALITY AND INFLUENCE OF TOTAL-BODY IRRADIATION MODALITIES
    Bone marrow transplantation
    
    L. Sutton et al., "ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - FACTORS PREDICTIVE OF TRANSPLANT-RELATED MORTALITY AND INFLUENCE OF TOTAL-BODY IRRADIATION MODALITIES", Bone marrow transplantation, 12(6), 1993, pp. 583-589
89. COIGNET L; BERTHEAS MF; VASSELON C; JAUBERT J; REYNAUD J; CALMARDORIOL P; BRIZARD CP; GUYOTAT D
    TRISOMY-12 IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - INTERPHASE STUDY BY INSITU HYBRIDIZATION IN 75 PATIENTS
    Nouvelle revue francaise d'hematologie
    
    L. Coignet et al., "TRISOMY-12 IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - INTERPHASE STUDY BY INSITU HYBRIDIZATION IN 75 PATIENTS", Nouvelle revue francaise d'hematologie, 35(2), 1993, pp. 129-134
90. TARDY B; TARDYPONCET B; PAGE Y; DECOUSUS H; GUYOTAT D; BERTRAND JC
    LOW-MOLECULAR-WEIGHT HEPARIN FOR HICKMAN CATHETER-INDUCED THROMBOSIS IN THROMBOCYTOPENIC PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION
    Cancer
    
    B. Tardy et al., "LOW-MOLECULAR-WEIGHT HEPARIN FOR HICKMAN CATHETER-INDUCED THROMBOSIS IN THROMBOCYTOPENIC PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION", Cancer, 71(9), 1993, pp. 2882-2883
91. CAMPOS L; GUYOTAT D
    BCL-2 ANTISENSE OLIGODEOXYNUCLEOTIDES BLOCK IN-VITRO PROLIFERATION AND SURVIVAL OF NORMAL MARROW PROGENITORS AND MYELOID-LEUKEMIA CELLS
    Blood
    
    L. Campos e D. Guyotat, "BCL-2 ANTISENSE OLIGODEOXYNUCLEOTIDES BLOCK IN-VITRO PROLIFERATION AND SURVIVAL OF NORMAL MARROW PROGENITORS AND MYELOID-LEUKEMIA CELLS", Blood, 82(10), 1993, pp. 10000119-10000119
92. PIGNON B; HAROUSSEAU JL; WITZ F; DESABLENS B; LEPRISE PY; BOASSON M; LINASSIER C; ABGRALL JF; SOLARY E; LIOURE B; CAHN JY; CASASSUS P; SADDOUN A; AUDHUY B; GUYOTAT D; BRIERE J; VILQUE JP; DANEL P; BERTHAUD P
    INDUCTION THERAPY FOLLOWED BY A UNIQUE INTENSIVE CONSOLIDATION COURSEIN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AGED 50 TO 65 - RESULTS OF THE GOELAM GROUP
    Blood
    
    B. Pignon et al., "INDUCTION THERAPY FOLLOWED BY A UNIQUE INTENSIVE CONSOLIDATION COURSEIN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AGED 50 TO 65 - RESULTS OF THE GOELAM GROUP", Blood, 82(10), 1993, pp. 10000127-10000127
93. THOMAS X; MICHALLET M; JAUBERT J; TRONCY J; GUYOTAT D; FIERE D; ARCHIMBAUD E
    PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION (BMT) IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA (AML)
    Blood
    
    X. Thomas et al., "PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION (BMT) IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA (AML)", Blood, 82(10), 1993, pp. 10000128-10000128
94. CAMPOS L; ROUAULT JP; SABIDO O; ORIOL P; ROUBI N; VASSELON C; ARCHIMBAUD E; MAGAUD JP; GUYOTAT D
    HIGH EXPRESSION OF BCL-2 PROTEIN IN ACUTE MYELOID-LEUKEMIA CELLS IS ASSOCIATED WITH POOR RESPONSE TO CHEMOTHERAPY
    Blood
    
    L. Campos et al., "HIGH EXPRESSION OF BCL-2 PROTEIN IN ACUTE MYELOID-LEUKEMIA CELLS IS ASSOCIATED WITH POOR RESPONSE TO CHEMOTHERAPY", Blood, 81(11), 1993, pp. 3091-3096